Scheduling BCG and IL-2 Injections for Bladder Cancer Immunotherapy Treatment
Cancer is one of the most common families of diseases today with millions of new patients every year around the world. Bladder cancer (BC) is one of the most prevalent types of cancer affecting both genders, and it is not known to be associated with a specific group in the population. The current tr...
Main Authors: | Amit Yaniv-Rosenfeld, Elizaveta Savchenko, Ariel Rosenfeld, Teddy Lazebnik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Mathematics |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-7390/11/5/1192 |
Similar Items
-
Cell-Level Spatio-Temporal Model for a Bacillus Calmette–Guérin-Based Immunotherapy Treatment Protocol of Superficial Bladder Cancer
by: Teddy Lazebnik
Published: (2022-08-01) -
Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
by: Maciej Jaromin, et al.
Published: (2024-03-01) -
APPROACHES TO PERSONALIZED THERAPY
by: F. I. Belyalov
Published: (2018-07-01) -
BCG Sepsis After Intravesical BCG Instillation: A Case Report
by: Meliha Çağla Sönmezer, et al.
Published: (2019-03-01) -
Novel therapies of treating non-muscle invasive bladder cancer when BCG therapy turns out to be insufficient
by: Magdalena Kołodziej, et al.
Published: (2024-04-01)